Item 6. Selected Financial Data.

3K characters. Original on sec.gov · Markdown

Item 6. Selected Financial Data.

Five Year Financial Highlights



Years Ended October 31, (In thousands, except per share amounts)	2014		2013		2012		2011		2010
Consolidated Operations
Net sales	$	1,717,776	$	1,587,725	$	1,445,136	$	1,330,835	$	1,158,517
Gross profit	$	1,091,570	$	1,026,808	$	924,010	$	804,804	$	676,723
Income before income taxes	$	296,534	$	312,271	$	275,452	$	192,764	$	124,426
Net income attributable to Cooper stockholders	$	269,856	$	296,151	$	248,339	$	175,430	$	112,803
Diluted earnings per share attributable to Cooper stockholders	$	5.51	$	5.96	$	5.05	$	3.63	$	2.43
Number of shares used to compute diluted earnings per share	48,960		49,685		49,152		48,309		46,505
Dividends paid per share	$	0.06	$	0.06	$	0.06	$	0.06	$	0.06
Consolidated Financial Position
Current assets	$	791,617	$	747,241	$	657,860	$	540,347	$	491,340
Property, plant and equipment, net	937,325		739,867		640,255		609,205		593,887
Goodwill	2,220,921		1,387,611		1,370,247		1,276,567		1,261,976
Other intangible assets, net	453,605		198,769		214,783		128,341		114,177
Other assets	54,872		63,773		58,239		70,058		63,638
	$	4,458,340	$	3,137,261	$	2,941,384	$	2,624,518	$	2,525,018
Short-term debt	$	101,518	$	42,987	$	25,284	$	52,979	$	19,159
Other current liabilities	340,664		278,266		237,268		214,227		180,361
Long-term debt	1,280,833		301,670		348,422		327,453		591,977
Other liabilities	146,885		90,844		117,252		92,371		66,745
Total liabilities	1,869,900		713,767		728,226		687,030		858,242
Stockholders' equity	2,588,440		2,423,494		2,213,158		1,937,488		1,666,776
	$	4,458,340	$	3,137,261	$	2,941,384	$	2,624,518	$	2,525,018

In our fiscal fourth quarter of 2014, Cooper acquired Sauflon Pharmaceuticals Limited, as discussed in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations and Note 2 of our notes to consolidated financial statements.

THE COOPER COMPANIES, INC. AND SUBSIDIARIES

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Previous: Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. · Next: Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations.